Abstract
Introduction:
Intensive care unit (ICU) admissions of very elderly patients (≥90 years) have increased in recent years. To date, it remains unclear if prolonged ICU treatment (≥7 days) is justified regarding outcome. Yet, factors associated with prolonged ICU stay remain unknown in the very elderly critically ill population.
Materials and methods:
This retrospective study analysed all adult patients aged ≥90 years consecutively admitted to the ICU at a tertiary care centre in Hamburg, Germany, (01/01/2008–03/31/2019). Multivariable regression and Kaplan–Meier estimates were employed to assess the independent predictors of a prolonged ICU stay.
Results:
Of 1,091 very elderly patients admitted to the ICU, 10% (n = 110) experienced a prolonged ICU stay (≥7 days). Demographic characteristics, including age, gender, and body mass index (BMI)—were similar across groups. Patients with extended stays had higher admission SAPS II and SOFA scores (47 vs. 35 and 5 vs. 2 points, respectively, p < 0.001 for both). The requirement for mechanical ventilation (MV) and renal replacement therapy (RRT) was higher in the prolonged stay group (78 and 12%, respectively) compared to the shorter-stay group (30 and 2%, respectively, p < 0.001 for both). Multivariate regression analysis identified MV [OR 3.873, 95% CI (2.026–7.406); p < 0.001], vasopressors [OR 2.921, 95% CI (1.466–5.821); p = 0.002], RRT [OR 4.299, 95% CI (1.513–12.212); p = 0.006] and SAPS II [OR 1.023, 95% CI (1.004–1.043); p = 0.020] as independent intra ICU markers associated with a prolonged stay. ICU and hospital mortality rates were higher in the prolonged stay group (32 and 50%, respectively) compared to those with shorter stays (17 and 28%, respectively, p < 0.001 for all).
Conclusion:
Approximately 10% of critically ill patients aged 90 years and above experienced prolonged ICU stays which was significantly associated with increased mortality. Prolonged ICU therapy has little long-term benefit and high mortality. Therefore, providing prolonged ICU treatment must be carefully considered incorporating individual frailty, premorbid function, and goals of care.
Background
The global population is currently experiencing a decrease in fertility rates alongside increased life expectancy, leading to a rapid aging demographic. A significant aspect of this shift is the growth in the population of very elderly individuals, with projections indicating that by 2030, the number of nonagenarians will surpass 30 million (1). Due to this demographic development and advancements in providing medical care, the proportion of very elderly patients admitted to the intensive care unit (ICU) is expected to rise substantially. Presently, approximately 15% of critically ill patients in ICU present at an advanced age of 80 years and above; 1% was observed to be beyond 90 years of age (2, 3). While studies have reported acceptable outcomes among this age group, debates on limitation of therapy and futility of care in this age group remain subject of considerable debate (3, 4). Nonetheless, age alone should be a determining factor in withholding critical care (3).
The median length of ICU stay in nonagenarians ranges from 1.4 to 6.1 days, depending on the patient groups studied, however, a majority can be discharged within 7 days or less (3, 5, 6). In contrast, a prolonged ICU stay is generally associated with increased mortality and unfavourable functional outcomes (7–9). With continuous advancements in medical treatments, it is anticipated that an increasing number of patients will experience extended ICU stays, including those at advanced age (10). This will pose challenges in decision-making concerning treatment intensity and futility of care, particularly in cases with unanticipated outcomes. Among the general ICU population, age was identified as relevant risk factor in patients with very prolonged ICU stays (11–13). Notably, prolonged mechanical ventilation (MV) as well as length of ICU stay (LOS) are associated with impaired long-term survival and unfavourable quality of life, especially in the very elderly (7–9, 14–16). Additionally, functional outcomes post-prolonged critical illness tend to be poorer and often persistent, necessitating careful consideration in the management of these cases (15). Despite these concerns, there remains a notable scarcity of studies on the characteristics and outcomes of nonagenarians, specifically in those with an extended ICU stay.
Therefore, the primary objective of this study was to investigate the incidence of prolonged ICU stay (≥7 days). Further clinical characteristics, risk factors, and outcomes to identify patients at risk for a prolonged intensive care therapy will be investigated.
Patients and methods
Study design, setting and ethics
Data of all adult patients ≥90 years consecutively admitted to the Department of Intensive Care Medicine at the University Medical Centre Hamburg-Eppendorf (Germany) between January 2008 and March 2019 were analysed. The department constitutes of 12 intensive care units (ICU) and cares for all critically ill adult patients of the hospital with a total capacity of 140 beds.
Inclusion and exclusion criteria
All adult patients (≥90 years) admitted to the ICU were included in the study. All patients <90 years of age, or patients with incomplete clinical data were excluded.
Data collection
Data were documented prospectively by trained staff. Second, we show results of a large tertiary care centre experienced in the management of critically ill patients. Data was then collected through electronic patient data management system (PDMS, Integrated Care Manager® (ICM)—Draeger Medical, Luebeck, Germany). The extracted data included age, sex, comorbidities, admission diagnosis, length of ICU- and hospital-stay, outcome, treatment modalities and organ support (mechanical ventilation, vasopressor, renal replacement therapy, blood transfusions, antibiotics, antivirals, etc.) and laboratory parameters. Laboratory assessment was performed on daily basis within clinical routine.
Study definitions and patient management
Prolonged ICU stay was defined as continuous presence in the ICU for a period of 7 days or more. To evaluate the severity of illness upon admission, the Sequential Organ Failure Assessment (SOFA) (17) and Simplified Acute Physiology Score II (SAPS II) (18) were utilised. The Charlson comorbidity index (CCI) (19) was calculated for each patients to assess their comorbidity burden.
Study definitions and patient management
We defined incidence of prolonged ICU stay (≥7 days) as primary outcome. Furthermore, we defined ICU mortality, hospital mortality, 1-year mortality, hospital length of stay as secondary outcomes.
Statistical analysis
Data are presented as absolute numbers and relative frequency or median with interquartile range (IQR) as appropriate. Categorical variables were compared using either chi-square-analysis or Fisher’s exact test. For continuous variables, Mann–Whitney-U test was employed. Exposures were assessed either at ICU admission or at any time during the ICU stay, as specified for each variable. Some exposures are time-dependent, and competing risks were considered when interpreting associations. Patient factors associated with the occurrence of prolonged ICU stay and mortality were assessed. Therefore, multivariable logistic regression analysis using clinically available variables was performed employing a stepwise backward elimination approach to derive the model; variables that exhibited a change in estimates >10% and with maintained statistical significance were included in the model. Statistical analysis was conducted using IBM SPSS Statistics Version 24.0 (IBM Corp., Armonk, NY). Throughout the analysis, a p-value <0.05 was deemed statistically significant. The study was prepared in accordance with the STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) recommendations (20).
Results
Overview and primary outcome
During the study period from January 1st, 2008 to March 31st, 2019 a total number of 92,190 patients were treated at the department of intensive care medicine. After the exclusion of 17 cases due to incomplete data 1,091 patients ≥90 years were identified and included in this study (see flow chart—Figure 1). In this study the primary outcome is incidence of a prolonged ICU stay. Of 1,091 very elderly patients admitted to the ICU, 10% (n = 110) experienced a prolonged ICU stay (≥7 days).
Figure 1

Flow chart of the study.
Study population
The median age of the patients was 92.3 years (IQR: 91.0–94.2) and 32% (n = 350) were male. The median body mass index was 23.4 kg/m2 (IQR: 21.0–26.0). Patients were admitted to the ICU due to medical reasons (34%, n = 373), elective surgery (37%, n = 402), and emergency surgery (28%, n = 309) surgery. The severity of disease, as represented by the SAPS II and SOFA score, had a median of 36 points (IQR: 28–47) and 2 points (IQR: 1–5) on admission, respectively. The burden of disease as assessed by the CCI was 1 (IQR: 0–2) was observed in our cohort. Arterial hypertension (70%, n = 762), chronic kidney disease (23%, n = 249) and congestive heart failure (22%, n = 241) were the most frequent comorbidities observed. On the day of admission, 22% (n = 238) received invasive mechanical ventilation (MV) and non-invasive mechanical ventilation (NIV) or high-flow nasal cannula (HFNC) in 7% (n = 77). Additionally, vasopressor therapy was necessary in 33% (n = 363) of patients. The median duration of ICU and hospital stay was 1.6 (IQR: 0.9–3.5) and 11.0 (7.0–16.6) days, respectively. The ICU mortality was 18% (n = 199) and the hospital mortality was 30% (n = 328) (see Table 1).
Table 1
| Variables | All (n = 1,091) |
|---|---|
| Age (years) | 92.3 (91.0–94.2) |
| Males | 350 (32) |
| Weight (kg) | 65 (55–74) |
| Height (cm) | 165 (160–170) |
| BMI (kg/m2) | 23.4 (21.0–26.0) |
| Primary admission | |
| Medical | 373 (34) |
| Surgical—planned | 402 (37) |
| Surgical—emergency | 309 (28) |
| Disease severity | |
| SAPS II—admission (pts.) | 36 (28–47) |
| SOFA—admission (pts.) | 2 (1–5) |
| Comorbidities | |
| Charlson comorb. index, pts. | 1 (0–2) |
| Arterial hypertension (n, %) | 762 (70) |
| Chronic kidney disease (n, %) | 249 (23) |
| Coronary heart disease (n, %) | 169 (16) |
| Congestive heart failure (n, %) | 241 (22) |
| Diabetes mellitus (n, %) | 148 (14) |
| Chronic lung disease (n, %) | 88 (8) |
| Vital functions—admission | |
| Body temperature (C°) | 36.2 (35.5–36.8) |
| Heart rate (beats/min) | 80 (65–97) |
| Mean arterial pressure (mmHg) | 86 (72–102) |
| Vasopressor use | 363 (33) |
| Respiratory support—admission | |
| Invasive mechanical ventilation | 238 (22) |
| Non-invasive ventilation/HFNC | 77 (7) |
| Outcome | |
| Duration ICU stay (days) | 1.6 (0.9–3.5) |
| Duration hospital stay (days) | 11.0 (7.0–16.6) |
| Died in ICU | 199 (18) |
| Died in hospital | 328 (30) |
Baseline characteristics of the study population.
Data are expressed as n (%) or median (interquartile range).
kg, kilogram; m, meter; ICU, intensive care unit; BMI, body mass index; pts., points; HFNC, high-flow nasal cannula.
Occurrence and clinical characteristics of patients with and without prolonged intensive care unit stay
Detailed characteristics are demonstrated in Table 2. Demographic characteristics including age, gender and BMI were comparable in patients with and without prolonged ICU stay. Patients with prolonged ICU stay were admitted to the ICU due medical reasons (49% vs. 33%, p = 0.001), elective surgical (25% vs. 38%, p = 0.009) and emergency surgical (24% vs. 29%, p = 0.250) as compared to patients without prolonged ICU stay, respectively. The median CCI did not differ between both groups [1 (IQR: 0–3) vs. 1 (IQR: 1–2), p = 0.933]. Detailed comorbidities are presented in Supplementary Table 1. At admission SAPS II [47 (IQR: 37–65) vs. 35 (IQR: 27–45), p < 0.001] and SOFA [5 (IQR: 3–9) vs. 2 (IQR: 1–5), p < 0.001] were higher in patients with a prolonged stay; as they were 24 h after admission [SOFA: 5 (IQR: 3–10) vs. 2 (IQR: 1–4)].
Table 2
| Variables | Prolonged stay (≥7 days) (n = 110) | Non-prolonged stay (<7 days) (n = 981) | p-value |
|---|---|---|---|
| Age (years) | 92.2 (90.8–93.8) | 92.3 (91.0–94.2) | 0.389 |
| Males | 43 (39) | 307 (31) | 0.097 |
| BMI (kg/m2) | 23.4 (21.5–26.2) | 23.4 (20.8–26.0) | 0.624 |
| Primary admission | |||
| Medical | 54 (49) | 319 (33) | 0.001 |
| Surgical—planned | 28 (25) | 374 (38) | 0.009 |
| Surgical—emergency | 26 (24) | 283 (29) | 0.25 |
| Disease severity | |||
| Charlson comorb. index, pts. | 1 (0–3) | 1 (1–2) | 0.933 |
| SAPS II—admission (pts.) | 47 (37–56) | 35 (27–45) | <0.001 |
| SOFA—admission (pts.) | 5 (3–9) | 2 (1–5) | <0.001 |
| SOFA—24 h (pts.) | 5 (3–10) | 2 (1–4) | <0.001 |
| Respiratory support | |||
| Invasive MV | 86 (78) | 296 (30) | <0.001 |
| Duration of MV (days) | 2.6 (0.7–6.2) | 0.4 (0.2–1.0) | <0.001 |
| Procedures/Therapies | |||
| Vasopressors | 92 (84) | 366 (37) | <0.001 |
| Renal replacement therapy | 13 (12) | 17 (2) | <0.001 |
| Parenteral Nutrition | 21 (19) | 57 (6) | <0.001 |
| Cardiopulmonary resuscitation | 18 (16) | 64 (7) | <0.001 |
| Hypoxic liver injury | 10 (9) | 25 (3) | <0.001 |
| Jaundice >3 mg/dL | 4 (4) | 9 (1) | 0.013 |
| Outcome | |||
| Duration ICU stay (days) | 10.1 (8.1–12.8) | 1.3 (0.9–2.6) | <0.001 |
| Duration hospital stay (days) | 16.1 (11.7–20.4) | 10.2 (6.3–16.0) | <0.001 |
| Died in ICU | 35 (32) | 164 (17) | <0.001 |
| Died in hospital | 55 (50) | 273 (28) | <0.001 |
ICU characteristics of patients with and without prolonged ICU-stay.
Data are expressed as n (%) or median (interquartile range).
ICU, intensive care unit; BMI, body mass index; kg, kilogram; m, meter; pts., points; mv, mechanical ventilation; LDH, lactate-dehydrogenase; CRP, C-reactive protein.
The need for invasive mechanical ventilation was higher [78% (n = 86) vs. 30% (n = 296), p < 0.001] and ventilation episodes were longer [2.6 days (IQR: 0.7–6.2) vs. 0.4 days (IQR: 0.2–10), p < 0.001] in the subgroup of patients with a prolonged ICU stay. 84% (n = 92) and 37% (n = 366) patients with and without prolonged ICU stay received vasopressor therapy, respectively (p < 0.001). Twelve percent (n = 13) in the prolonged ICU stay group underwent RRT, while this was necessary in only 2% (n = 17) of patients with shorter ICU stays (p < 0.001). Parenteral nutrition therapy, alone or together with enteral nutrition, was applied in 19% (n = 21) with prolonged ICU stay and in 6% (n = 57) without prolonged ICU stay (p < 0.001). The ICU stay was complicated due to hypoxic liver injury (9% vs. 3%, p < 0.001), jaundice (4% vs. 1%, p < 0.001) and cardiopulmonary resuscitation (16% vs. 7%, p < 0.001).
Laboratory and blood gas analysis on admission
On admission, haemoglobin (10.4 vs. 10.3 g/dL, p = 0.975), and leukocyte (11.6 vs. 10.7 /nL, p = 0.057) levels were comparable, while LDH levels were found to be significantly higher in the prolonged stay group (292 vs. 251 U/L, p = 0.011); furthermore, both CRP [59 (IQR: 17–125) vs. 27 (IQR: 8–75) mg/L, p = 0.001] and serum creatinine [1.3 (0.8–2.0) vs. 1.1 (0.8–1.6) mg/dL, p = 0.005] were higher. Median thrombocyte and bilirubin levels were comparable and in normal ranges in both groups. Parameters obtained from arterial blood gas analysis pH, bicarbonate, oxygen and carbon dioxide partial pressures were similar in both groups. In contrast, median serum lactate levels differed slightly [1.3 (IQR: 0.9–2.3) vs. 1.1 (0.8–1.7) mmol/L, p = 0.002] at admission, while this difference was more pronounced comparing their median peak serum level [2.4 (1.8–3.9) vs. 1.7 (1.1–2.6) mmol/L, p < 0.001]. For detailes please see Supplementary Table 2.
Factors during the ICU stay associated with a prolonged stay
Multivariate regression analysis identified mechanical ventilation [OR 3.873, 95% CI (2.026–7.406); p < 0.001], requirement of vasopressors [OR 2.921, 95% CI (1.466–5.821); p = 0.002], RRT [OR 4.299, 95% CI (1.513–12.212); p = 0.006], and SAPS II [OR 1.023, 95% CI (1.004–1.043); p = 0.020] were identified as associated intra ICU markers with a prolonged stay (see Table 3).
Table 3
| Logistic regression | Covariables | OR (95% CI) | p-value |
|---|---|---|---|
| Final model | SAPS II | 1.023 (1.004–1.043) | 0.020 |
| Mechanical ventilation—during ICU (yes vs. no) | 3.873 (2.026–7.406) | <0.001 | |
| Vasopressors—during ICU (yes vs. no) | 2.921 (1.466–5.821) | 0.002 | |
| Renal replacement therapy—during ICU (yes vs. no) | 4.299 (1.513–12.212) | 0.006 |
Multivariable logistic regression for factors associated with occurrence of prolonged ICU stay.
Multivariable logistic regression for factors associated prolonged ICU stay (variables included in the initial model: gender, Simplified Acute Physiology Score (SAPS) II at admission, Charlson comorbidity index, mechanical ventilation during ICU, vasopressors during ICU, Sepsis-related Organ Failure Assessment (SOFA) score, body-mass-index, renal replacement therapy during ICU). OR, odds ratio; CI, confidence interval; SAPS II, Simplified Acute Physiology Score II; ICU, intensive care unit.
Outcomes and secondary outcomes of patients with and without prolonged intensive care unit stay
The median length of stay in the ICU was significantly longer in the prolonged ICU stay group, recorded at 10.1 days (IQR: 8.1–12.8), compared to 1.3 days (IQR: 0.9–2.6) in the shorter stay group. Similarly, the median hospital stay was also notably longer, being 16.1 days (IQR: 11.7–20.4) in the prolonged stay group vs. 10.2 days (IQR: 6.3–16.0) in the other group (p < 0.001 for both).
In the cohort of patients with prolonged ICU stays, the observed ICU, hospital, and 1-year mortality rates were notably higher, at 32, 50, and 75%, respectively; compared to 17, 28, 55% and in patients without prolonged ICU stays (p < 0.001 each). Furthermore, the one-year long-term mortality rate was significantly greater in patients with prolonged ICU stays, standing at 75% (n = 83), as opposed to 55% (n = 541) in those with non-prolonged stays (refer to Figure 2).
Figure 2

Survival stratified according prolonged and non-prolonged ICU-stay.
Discussion
In this study of patients ≥90 years admitted to the ICU, we found that 10% of the patients required a prolonged ICU stay (≥7 days) which was associated with a significantly higher short- and long-term mortality. To our knowledge, this is the first study investigating occurrence, outcome and factors associated with presence of prolonged ICU stay among very elderly critically ill patients.
Across all ages, the average ICU length of stay usually ranges between 1.4 to 6.1 days, with the majority of patients requiring a stay below 7 days (3, 5, 6, 21). Additionally, for elderly patients not requiring critical care, prolonged hospital stays have been reported to be associated with an increased rate of complications and unfavourable outcome, including hospital re-admission, mortality, as well as deterioration of functional status (22). In their paper on the syndrome of the “chronically critically ill,” Girard and Raffin (23) described a patient group surviving an initial episode of critical illness, however, failing to recover beyond the point of becoming independent of critical care (“neither dying nor recovering”). Respiratory failure and prolonged dependence on invasive ventilation constitute the hallmarks of chronic critical illness. It is estimated that between five to 10% of patients who undergo invasive ventilation initially will eventually become part of this chronically critically ill group (11, 24). It appears reasonable to expected that this proportion will be significantly higher the group of nonagenarians, especially in those with a prolonged ICU stay.
The population of patients with a prolonged stay in the ICU is consuming a high number of ICU resources (25–29). This issue takes on particular significance in the context of limited bed capacity, which is often exacerbated by constraints in nursing staff availability. Furthermore, while most published studies report to be favourable cost-efficiency ratios (less than $50,000 per quality-adjusted life year), a review by Wilcox et al. (30) found that 17% (n = 20) of studies indicated cost-efficiency-ratios surpassing $100,000 per quality adjusted life year.
Recent trends in population aging, along with advancements in critical care management, have been identified as key factors contributing to the increasing number of patients experiencing prolonged ICU stays (1, 10, 11). However, due to the large heterogeneity within this patient group, a universally accepted definition of “prolonged ICU stay” has yet to be established. In the distinct cohort of nonagenarians investigated in this study, an ICU stay beyond 7 days was observed in 10%. In those, a clear association with an underlying medical condition could be established, affecting approximately half of them.
In this study, the overall severity of illness was low. Nonetheless, patients admitted with a higher SOFA and SAPS II scores were at increased risk for prolonged ICU stays. Notably, during their extended time in the ICU, more than 80% of patients required vasopressor support. It is important to note, though, that this high proportion may be influenced by the inclusion of patients suffering cardiac arrest, with potential high rates of post-cardiac arrest shock or heart failure (31, 32).
Interestingly, we observed a high rate of hypoxic liver injury and cholestasis in patients with a prolonged ICU stay. This might be attributed to the common co-occurrence of hypoxic liver injury in severe illness and might be observed in settings of cardiac, circulatory, or respiratory failure (33, 34).
Acute kidney injury frequently complicates ICU stay, often mirroring severity of illness (35). Indeed, 10% of patients in the prolonged stay group required renal replacement therapy. The occurrence of organ failure was notably influential in the development of prolonged ICU stays in this cohort.
Due to the growing complexity of medical interventions, even in advanced age (such as trans-femoral aortic valve implantation, TAVI), along with the management of ensuing complications, as well as advancements in intensive care medicine, it is anticipated that a greater number of patients will experience prolonged lengths of stay in the ICU (10). This is accompanied with challenges in decision making on the treatment intensity and futility of care. Physical function and cognitive status following (prolonged) critical illness are frequently poorer and more enduring than initially anticipated: Studies reveal that less than 12% of chronically critically ill patients are alive and independent a year after acute illness. This situation places heavy burdens on families, leading to high rates of depression and caregiver burnout. Notably, the decline in caregivers’ physical health and the increased stress are prevalent not just in home care settings but are often at least as severe for families of institutionalized patients (11, 15).
Recent research underscores the significant impact of frailty on mortality among critically ill, very elderly patients (36, 37). Consequently, frailty should be a critical consideration in ICU treatment discussions. Although frailty was not directly assessed in our cohort, we noted that 61% of patients lived independently prior to their ICU admission, while the remainder resided in nursing homes or assisted living facilities, suggesting they might be more vulnerable and presumably frailer. Contrary to expectations, a recent study found the most significant impact of frailty on mortality risk in middle-aged patients, rather than in the very elderly. Consequently, frailty should not be the sole determinant in excluding very elderly patients from critical care therapy, highlighting the need for a more nuanced approach in decision-making (38).
Although, we observed an increased ICU- and 1-year mortality in patients with a prolonged ICU stay, survival rates were acceptable considering the advanced patient age. However, the clinical situation and potential deteriorations should be perceived early and treatment intensity should be adapted according patients and family wishes to optimise compassionate care while avoiding futile life-sustaining interventions.
This study has several limitations: First, we show the results of a retrospective single centre study alongside with its limitations. However, data were documented prospectively by trained staff. Second, we show results of a large tertiary care centre experienced in the management of critically ill patients. Therefore, results and conclusions may not be transferable to other settings. Third, in the logistic regression model we applied a stepwise selection method which can produce an unstable model and biased estimates, particularly in datasets with a limited number of events. However, we used a stepwise selection with the intend to explore associations in an observational dataset rather than to infer causality. Fourth, we acknowledge that some exposures are time-dependent and that competing risks may influence observed associations. The timing of exposure measurement—either at ICU admission or during the ICU stay—may limit causal interpretation and should be considered when applying these findings clinically. Fifth, residual confounding from unmeasured covariables is a matter of concern and cannot be entirely excluded.
Conclusion
Our study demonstrated that prolonged ICU stays of nonagenarians are not uncommon and are associated with little long-term benefit, which, however, may be considered acceptable given the advanced age of the patients. Intra ICU markers associated with prolonged ICU stays included mechanical ventilation, vasopressor therapy, and renal replacement therapy. These findings suggest that prolonged ICU therapy for critically ill nonagenarians can be beneficial and should generally not be pre-emptively withheld. Due to limited physical reserves in this population, patients’ propensity to recover is low even when treated for a relatively short period of time in the ICU. Nevertheless, decisions regarding such therapy must be tailored, taking into account individual patient factors (e.g., individual frailty, premorbid function, and goals of care) for a more personalised approach, also integrating the expertise and realistic judgment of experienced medical professionals.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving humans were approved by Ethikkomission der Ärztekammer Hamburg. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements.
Author contributions
MH: Conceptualization, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing. JM: Conceptualization, Investigation, Project administration, Supervision, Validation, Writing – review & editing. RD: Conceptualization, Data curation, Investigation, Methodology, Project administration, Writing – review & editing. PT: Conceptualization, Data curation, Investigation, Methodology, Project administration, Writing – review & editing. SK: Conceptualization, Data curation, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – review & editing. KR: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing.
Funding
The author(s) declared that financial support was received for this work and/or its publication. We acknowledge financial support from the Open Access Publication Fund of UKE - Universitätsklinikum Hamburg-Eppendorf.
Acknowledgments
An abstract of the current study has been presented at the ESICM LIVES Congress 2023 in Milan, Italy.
Conflict of interest
SK received research support by Ambu, E.T.View Ltd., Fisher & Paykel, Pfizer and Xenios, lecture honorarium from ArjoHuntleigh, Astellas, Astra, Basilea, Bard, Baxter, Biotest, CSL Behring, Cytosorbents, Fresenius, Gilead, MSD, Orion, Pfizer, Philips, Sedana, Sorin, Xenios and Zoll, and consultant honorarium from AMOMED, Astellas, Baxter, Bayer, Fresenius, Gilead, MSD, Pfizer and Xenios. KR received travel reimbursement from Gilead within the last 5 years.
The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that Generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2025.1728917/full#supplementary-material
Supplementary Table 1Pre-existing comorbidities comparing prolonged stay vs. non-prolonged stay.
Supplementary Table 2ICU Characteristics of patients with and without prolonged ICU-stay.
References
1.
Kontis V Bennett JE Mathers CD Li G Foreman K Ezzati M . Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. (2017) 389:1323–35. doi: 10.1016/S0140-6736(16)32381-9,
2.
Nielsson MS Christiansen CF Johansen MB Rasmussen BS Tønnesen E Nørgaard M . Mortality in elderly ICU patients: a cohort study. Acta Anaesthesiol Scand. (2014) 58:19–26. doi: 10.1111/aas.12211,
3.
Becker S Muller J de Heer G Braune S Fuhrmann V Kluge S . Clinical characteristics and outcome of very elderly patients ≥90 years in intensive care: a retrospective observational study. Ann Intensive Care. (2015) 5:53. doi: 10.1186/s13613-015-0097-1,
4.
Pietiläinen L Hästbacka J Bäcklund M Parviainen I Pettilä V Reinikainen M . Premorbid functional status as a predictor of 1-year mortality and functional status in intensive care patients aged 80 years or older. Intensive Care Med. (2018) 44:1221–9. doi: 10.1007/s00134-018-5273-y,
5.
Somme D Maillet J-M Gisselbrecht M Novara A Ract C Fagon J-Y . Critically ill old and the oldest-old patients in intensive care: short- and long-term outcomes. Intensive Care Med. (2003) 29:2137–43. doi: 10.1007/s00134-003-1929-2,
6.
Garrouste-Orgeas M Ruckly S Grégoire C Dumesnil AS Pommier C Jamali S et al . Treatment intensity and outcome of nonagenarians selected for admission in ICUs: a multicenter study of the Outcomerea Research Group. Ann Intensive Care. (2016) 6:31. doi: 10.1186/s13613-016-0133-9,
7.
Chelluri L Im KA Belle SH Schulz R Rotondi AJ Donahoe MP et al . Long-term mortality and quality of life after prolonged mechanical ventilation. Crit Care Med. (2004) 32:61–9. doi: 10.1097/01.CCM.0000098029.65347.F9,
8.
Meinders AJ van der Hoeven JG Meinders AE . The outcome of prolonged mechanical ventilation in elderly patients: are the efforts worthwhile?Age Ageing. (1996) 25:353–6. doi: 10.1093/ageing/25.5.353,
9.
Arora RC Manji RA Singal RK Hiebert B Menkis AH . Outcomes of octogenarians discharged from the hospital after prolonged intensive care unit length of stay after cardiac surgery. J Thorac Cardiovasc Surg. (2017) 154:1668–78.e2. doi: 10.1016/j.jtcvs.2017.04.083,
10.
Vincent JL Singer M . Critical care: advances and future perspectives. Lancet. (2010) 376:1354–61. doi: 10.1016/S0140-6736(10)60575-2,
11.
Nelson JE Cox CE Hope AA Carson SS . Chronic critical illness. Am J Respir Crit Care Med. (2010) 182:446–54. doi: 10.1164/rccm.201002-0210CI,
12.
Carson SS Bach PB . The epidemiology and costs of chronic critical illness. Crit Care Clin. (2002) 18:461–76. doi: 10.1016/S0749-0704(02)00015-5,
13.
Kahn JM Le T Angus DC Cox CE Hough CL White DB et al . The epidemiology of chronic critical illness in the United States*. Crit Care Med. (2015) 43:282–7. doi: 10.1097/CCM.0000000000000710,
14.
Carson SS Bach PB Brzozowski L Leff A . Outcomes after long-term acute care. An analysis of 133 mechanically ventilated patients. Am J Respir Crit Care Med. (1999) 159:1568–73. doi: 10.1164/ajrccm.159.5.9809002,
15.
Delle Karth G Meyer B Bauer S Nikfardjam M Heinz G . Outcome and functional capacity after prolonged intensive care unit stay. Wien Klin Wochenschr. (2006) 118:390–6. doi: 10.1007/s00508-006-0616-z,
16.
Carson SS Garrett J Hanson LC Lanier J Govert J Brake MC et al . A prognostic model for one-year mortality in patients requiring prolonged mechanical ventilation. Crit Care Med. (2008) 36:2061–9. doi: 10.1097/CCM.0b013e31817b8925,
17.
Vincent JL Moreno R Takala J Willatts S De Mendonca A Bruining H et al . The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. (1996) 22:707–10. doi: 10.1007/BF01709751
18.
Le Gall JR Lemeshow S Saulnier F . A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. (1993) 270:2957–63. doi: 10.1001/jama.1993.03510240069035,
19.
Charlson ME Pompei P Ales KL MacKenzie CR . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. (1987) 40:373–83. doi: 10.1016/0021-9681(87)90171-8,
20.
von Elm E Altman DG Egger M Pocock SJ Gøtzsche PC Vandenbroucke JP . The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. (2007) 370:1453–7. doi: 10.1016/S0140-6736(07)61602-X,
21.
Daniels R Muller J Jafari C Theile P Kluge S Roedl K . Evolution of clinical characteristics and outcomes of critically ill patients 90 years old or older over a 12-year period: a retrospective cohort study. Crit Care Med. (2024) 52:e258–67. doi: 10.1097/CCM.0000000000006215,
22.
Bo M Fonte G Pivaro F Bonetto M Comi C Giorgis V et al . Prevalence of and factors associated with prolonged length of stay in older hospitalized medical patients. Geriatr Gerontol Int. (2016) 16:314–21. doi: 10.1111/ggi.12471,
23.
Girard K Raffin TA . The chronically critically ill: to save or let die?Respir Care. (1985) 30:339–47.
24.
Roedl K Jarczak D Boenisch O de Heer G Burdelski C Frings D et al . Chronic critical illness in patients with COVID-19: characteristics and outcome of prolonged intensive care therapy. J Clin Med. (2022) 11:1049. doi: 10.3390/jcm11041049,
25.
Weissman C . Analyzing the impact of long-term patients on ICU bed utilization. Intensive Care Med. (2000) 26:1319–25. doi: 10.1007/s001340000612,
26.
Williams MR Wellner RB Hartnett EA Thornton B Kavarana MN Mahapatra R et al . Long-term survival and quality of life in cardiac surgical patients with prolonged intensive care unit length of stay. Ann Thorac Surg. (2002) 73:1472–8. doi: 10.1016/S0003-4975(02)03464-1,
27.
Zampieri FG Ladeira JP Park M Haib D Pastore CL Santoro CM et al . Admission factors associated with prolonged (>14 days) intensive care unit stay. J Crit Care. (2014) 29:60–5. doi: 10.1016/j.jcrc.2013.09.030,
28.
Bagshaw SM Stelfox HT Iwashyna TJ Bellomo R Zuege D Wang X . Timing of onset of persistent critical illness: a multi-centre retrospective cohort study. Intensive Care Med. (2018) 44:2134–44. doi: 10.1007/s00134-018-5440-1,
29.
Roedl K Amann D Eichler L Fuhrmann V Kluge S Muller J . The chronic ICU patient: is intensive care worthwhile for patients with very prolonged ICU-stay (≥ 90days)?Eur J Intern Med. (2019) 69:71–6. doi: 10.1016/j.ejim.2019.08.024,
30.
Wilcox ME Vaughan K Chong C Neumann PJ Bell CM . Cost-effectiveness studies in the ICU: a systematic review. Crit Care Med. (2019) 47:1011–7. doi: 10.1097/CCM.0000000000003768,
31.
Roedl K Jarczak D Becker S Fuhrmann V Kluge S Muller J . Long-term neurological outcomes in patients aged over 90 years who are admitted to the intensive care unit following cardiac arrest. Resuscitation. (2018) 132:6–12. doi: 10.1016/j.resuscitation.2018.08.020,
32.
Roedl K Spiel AO Nurnberger A Horvatits T Drolz A Hubner P et al . Hypoxic liver injury after in- and out-of-hospital cardiac arrest: risk factors and neurological outcome. Resuscitation. (2019) 137:175–82. doi: 10.1016/j.resuscitation.2019.02.038,
33.
Horvatits T Drolz A Trauner M Fuhrmann V . Liver injury and failure in critical illness. Hepatology. (2019) 70:2204–15. doi: 10.1002/hep.30824,
34.
Roedl K Daniels R Theile P Fuhrmann V Kluge S Müller J . Occurrence, characteristics, and outcome of hypoxic liver injury among patients aged ≥90 years admitted to the intensive care unit: a retrospective cohort study. Gerontology. (2023) 69:728–36. doi: 10.1159/000529228,
35.
Mo S Bjelland TW Nilsen TIL Klepstad P . Acute kidney injury in intensive care patients: incidence, time course, and risk factors. Acta Anaesthesiol Scand. (2022) 66:961–8. doi: 10.1111/aas.14100,
36.
de Lange DW Soliman IW Leaver S Boumendil A Haas LEM Watson X et al . The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years. Ann Intensive Care. (2024) 14:46. doi: 10.1186/s13613-024-01246-w,
37.
Wernly B Bruno RR Beil M Flaatten H Kelm M Sigal S et al . Frailty's influence on 30-day mortality in old critically ill ICU patients: a Bayesian analysis evaluating the clinical frailty scale. Ann Intensive Care. (2023) 13:126. doi: 10.1186/s13613-023-01223-9,
38.
De Geer L Fredrikson M Chew MS . Frailty is a stronger predictor of death in younger intensive care patients than in older patients: a prospective observational study. Ann Intensive Care. (2022) 12:120. doi: 10.1186/s13613-022-01098-2,
Summary
Keywords
critical illness, critically ill, ICU, nonagenarians, prolonged ICU stay, very elderly
Citation
Haar M, Müller J, Daniels R, Theile P, Kluge S and Roedl K (2026) Prolonged intensive care therapy in nonagenarians admitted to the intensive care unit—clinical characteristics, risk factors and outcomes. Front. Med. 12:1728917. doi: 10.3389/fmed.2025.1728917
Received
20 October 2025
Revised
14 December 2025
Accepted
19 December 2025
Published
12 January 2026
Volume
12 - 2025
Edited by
Esra Ates Bulut, Ministry of Health (Türkiye), Türkiye
Reviewed by
Laszlo Zubek, Semmelweis University, Hungary
Nuanprae Kitisin, Mahidol University, Thailand
Updates
Copyright
© 2026 Haar, Müller, Daniels, Theile, Kluge and Roedl.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kevin Roedl, k.roedl@uke.de
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.